Last week, Moderna announced that it has received approval from the Food and Drug Administration (FDA) for the development of an mRNA vaccine for respiratory syncytial virus (RSV).
Former National Institute of Allergy and Infectious Diseases (NIAID) director Dr. Anthony Fauci appeared in front of the Committee on Oversight and Accountability in January to testify on COVID-19, the transcripts of which were recently released.
A censored study published by the National Institutes of Health (NIH) found that mRNA vaccines potentially alter the DNA of recipients and their offspring.